Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
COVID-19 prevalence survey update
COVID-19 prevalence survey update

Manatū Hauora – the Ministry of Health has agreed that the COVID-19 prevalence surveys should not advance in their proposed current format. Aotearoa New Zealand has passed the emergency stage of its COVID-19 response, with the virus endemic in our communities. The results of any COVID-19-focused prevalence survey would be unlikely to meaningfully alter any current public health response as there are only two pandemic-related mandates still in place (the 7-day isolation period and mask use for visitors to healthcare facilities).
COVID-19 infection prevalence and seroprevalence surveys are complex projects involving a number of agencies, stakeholders and external providers. The Ministry accepts it took longer than expected to reach this conclusion, given the challenges of a multi-stakeholder, complex project developed during the health reforms.
Prevalence surveys are expected to be a key tool in any future effective population and public health knowledge surveillance system. Any future survey design will benefit from lessons learned during the COVID-19 prevalence surveys project and, where appropriate, will leverage technologies and ways of working established during the pandemic.